APPLICATION
ANDA075300
TYPE
ANDA
ORIGINAL APPROVAL
2001-12-17
LATEST ACTION
2020-09-25
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
LOVASTATINPrescription
LOVASTATIN 20MG · TABLET · ORAL
LOVASTATINPrescription
LOVASTATIN 40MG · TABLET · ORAL
LOVASTATINPrescription
LOVASTATIN 10MG · TABLET · ORAL
Approval history
2020-09-25Labeling · Supplement 10 · standardAP
2017-08-04Labeling · Supplement 9 · standardAP
2005-08-18Labeling · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.